-
Saratoga Investment (SAR) PT Lowered to $22 at Compass Point
-
Saratoga Investment (SAR) Tops Q4 EPS by 2c
-
Janney Downgrades Saratoga Investment (SAR) to Neutral
-
Ladenburg Thalmann Assumes Saratoga Investment (SAR) at Neutral
-
Saratoga Investment (SAR) Misses Q3 EPS by 7c
-
Clear Street Starts Saratoga Investment (SAR) at Hold
-
Lucid Capital Markets Downgrades Saratoga Investment (SAR) to Neutral
-
Saratoga Investment (SAR) Misses Q2 EPS by 6c
-
Saratoga Investment (SAR) Raises Quarterly Dividend 1.4% to $0.75; 11.8% Yield
-
Saratoga Investment (SAR) PT Lowered to $25.25 at Compass Point
-
Saratoga Investment (SAR) Tops Q4 EPS by 6c
-
Lucid Capital Markets Starts Saratoga Investment (SAR) at Buy
-
After-hours movers: Astera Labs, Saratoga Investment, Kezar Life Sciences, and more
-
Saratoga Investment (SAR) Tops Q3 EPS by 3c
-
Saratoga Investment (SAR) Tops Q2 EPS by 9c


